Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia

The aim of this study is to optimize the timing of erythropoietin gene modified mesenchymal stem cells (EPO‐MSCs) transplantation for bronchopulmonary dysplasia (BPD). Three weeks post‐operation, the results indicated that the damage of airway structure and apoptosis were significantly decreased, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhaohua, Sun, Chao, Wang, Jue, Jiang, Wen, Xin, Qian, Luan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201357/
https://www.ncbi.nlm.nih.gov/pubmed/30160360
http://dx.doi.org/10.1111/jcmm.13843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201357/
https://www.ncbi.nlm.nih.gov/pubmed/30160360
http://dx.doi.org/10.1111/jcmm.13843

Ejemplares similares